院前乳酸酸中毒评分用于早期死亡的开发:一项前瞻性、多中心、基于救护车的队列研究
本研究为前瞻性、多中心、观察性推导-验证队列研究,纳入2020年1月1日至2021年12月31日期间由救护车转运并因急性疾病入住急诊科的成人,涉及6个高级生命支持单元、38个基础生命支持单元和4所医院(西班牙)。共纳入3334例患者,通过logistic回归从院前血液参数中推导出PLA评分,最终包含乳酸、pCO2和pH。主要终点2天全因死亡的AUC为0.941(95%CI 0.914-0.967),校准和净获益优于其他单一评分组分;次要终点ICU入院的AUC为0.75(95%CI 0.706-0.794)。作者认为将PLA评分纳入院前场景可能改善急诊服务的决策。
要点
- PLA评分由乳酸、pCO2和pH三项院前血液参数构成,用于预测院前成人2天全因死亡。
- 2天全因死亡:PLA评分AUC 0.941(95%CI 0.914-0.967),校准和净获益优于其他单一评分组分。
- ICU入院:PLA评分仅AUC表现较好,为0.75(95%CI 0.706-0.794)。
- 研究为前瞻性、多中心、观察性推导-验证队列,纳入3334例由救护车转运并入住急诊科的成人急性疾病患者。
- 作者认为将PLA评分纳入院前场景可能改善急诊服务的决策。
适用人群与场景
- 2020年1月1日至2021年12月31日期间由救护车转运并因急性疾病入住急诊科的成人。
- 研究场景为西班牙6个高级生命支持单元、38个基础生命支持单元,涉及4所医院。
诊断标准与关键阈值
- PLA评分由乳酸、pCO2和pH三项院前血液参数构成,通过logistic回归分析推导。
研究设计与关键结果
- 研究类型:前瞻性、多中心、观察性、推导-验证队列研究;样本量3334例;涉及6个高级生命支持单元、38个基础生命支持单元和4所医院(西班牙)。
- 主要终点2天全因死亡:PLA评分AUC 0.941(95%CI 0.914-0.967),校准和净获益优于其他单一评分组分。
- 次要终点ICU入院:PLA评分仅AUC表现较好,为0.75(95%CI 0.706-0.794)。
证据类型、等级与局限
- 证据类型:前瞻性、多中心、观察性、推导-验证队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为将PLA评分纳入院前场景可能改善急诊服务的决策。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Lactic acidosis is a clinical status related to clinical worsening. Actually, higher levels of lactate is a well-established trigger of emergency situations. The aim of this work is to build-up a prehospital early warning score to predict 2-day mortality and intensive care unit (ICU) admission, constructed with other components of the lactic acidosis besides the lactate.
METHODS: Prospective, multicenter, observational, derivation-validation cohort study of adults evacuated by ambulance and admitted to emergency department with acute diseases, between January 1st, 2020 and December 31st, 2021. Including six advanced life support, thirty-eight basic life support units, referring to four hospitals (Spain). The primary and secondary outcome of the study were 2-day all-cause mortality and ICU-admission. The prehospital lactic acidosis (PLA) score was derived from the analysis of prehospital blood parameters associated with the outcome using a logistic regression. The calibration, clinical utility, and discrimination of PLA were determined and compared to the performance of each component of the score alone.
RESULTS: A total of 3334 patients were enrolled. The final PLA score included: lactate, pCO2, and pH. For 2-day mortality, the PLA showed an AUC of 0.941 (95%CI: 0.914-0.967), a better performance in calibration, and a higher net benefit as compared to the other score components alone. For the ICU admission, the PLA only showed a better performance for AUC: 0.75 (95%CI: 0.706-0.794).
CONCLUSIONS: Our results showed that PLA predicts 2-day mortality better than other lactic acidosis components alone. Including PLA score in prehospital setting could improve emergency services decision-making.
参考来源
- Martín-Rodríguez F, Ortega GJ, Castro Villamor MA, et al. Development of a prehospital lactic acidosis score for early-mortality. A prospective, multicenter, ambulance-based, cohort study. Am J Emerg Med. 2022. PMID: 36580696. doi:10.1016/j.ajem.2022.12.030
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。